| Pharmaceutical active ingredients: |
| Lamivudine |
| Available forms, composition and doses of Zeffix: |
| Solution; Oral; Lamivudine 25 mg / 5 mlTablets, Film-Coated; Oral; Lamivudine 100 mgTablets; Oral; Lamivudine 100 mg |
| Zeffix medical category: |
| Human:AntiviralsNucleoside and nucleotide reverse transcriptase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AF05 - Lamivudine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineFirma Chun CheongZuellig Pharma |
| Related documents and information about Zeffix: |
| Zeffix prescribing information (PDF) |